ANAB vs BAC Stock Comparison

BAC currently leads ANAB in this stock comparison, with AIQ scores of 58 vs 56. The clearest difference is risk resilience, while ANAB has the stronger quality profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 2 points
ANAB
Healthcare
vs
BAC
Financial Services
ANAB
AnaptysBio, Inc.
Price
$46.25
Day move
-3.18%
AIQ Score
56/100
Best edge
Quality
Sector
Healthcare
BAC
Bank of America Corporation
Leads
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services

What is the main difference between ANAB and BAC?

BAC leads the current stock comparison as Bank of America Corporation, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

AnaptysBio, Inc. vs Bank of America Corporation

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

BAC leads

BAC leads by 2 AIQ points, primarily on Risk Resilience, but the lead has narrowed from 9 points over 30 sessions. Wall Street currently favors ANAB on target upside.

Fragile: 2 of 6 evidence groups support BAC, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 2 of 6Comparison trend: Weakening
ANAB

AnaptysBio, Inc.

AIQ Score
56/100
AIQ Edge Score
5/10
BAC

Bank of America Corporation

Leads
AIQ Score
58/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score currently favors BAC over ANAB, 58 versus 56 as of Nov 15, 2026. BAC's advantage is driven primarily by stronger risk resilience, while ANAB holds the stronger quality profile. BAC also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ANAB. 2 of 6 covered evidence groups favor BAC today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. BAC lead: Weakening — the AIQ differential moved from 9 to 2 points over 30 sessions.

Compare AnaptysBio, Inc. and Bank of America Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

ANAB
+45.6%
BAC
+24.0%

Total return comparison

Growth of $10,000, distributions reinvested

ANAB $14,558 · BAC $12,399

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare ANAB and BAC against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ANAB advantage
0
BAC advantage
  • Risk Resilience46 vs 83
    BAC +37
  • Quality72 vs 64
    ANAB +8
  • Value74 vs 68
    ANAB +6
  • Momentum36 vs 37
    Even

2 of 6 evidence groups favor BAC. BAC’s edge is concentrated in risk resilience; ANAB keeps a meaningful quality edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ANAB-1 AIQ

Largest factor move: Value -3

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Distribution Pattern — bearish, volume, medium horizon (1.22x)
BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)

BAC's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — ANAB and BAC both carry a full feed there.

The central trade-off

BAC (Bank of America Corporation): the stronger current systematic profile, led by risk resilience.

ANAB (AnaptysBio, Inc.): the counter-case, on quality, value, fundamentals — but at materially higher volatility, 51.8% against 24.8%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BAC

BAC on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

BAC

BAC on combined revenue and EPS growth.

Value

ANAB

ANAB on the peer-relative Value factor, by 6 points.

Momentum

Even

The two are level on Momentum.

Lower downside

BAC

BAC on Risk Resilience, by 37 points.

Analyst upside

ANAB

ANAB on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors BAC, analyst targets favor ANAB. That disagreement is the most useful thing on this page.

MeasureANABBACNote
Implied upside to target+75.1%+24.1%ANAB has more room
Target dispersion+30.9%+25.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering825Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 6 covered evidence groups favor BAC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven56 vs 58
FundamentalsANABon balancerevenue growth 10.1% vs -3.3%; EPS growth -97.9% vs -23.8%; TTM ROE 18.6% vs 2.3%; gross margin 143.7% vs 60.4%; operating margin 34.6% vs 22.4% — ANAB takes 4 of 5 decided legs, not all of them
ValuationANABValue 74 vs 68
TechnicalsBACPrice vs 50-day -7.1% vs -5.6%; vs 200-day -18.1% vs -7%
Risk ResilienceBACRisk Resilience 46 vs 83
Analyst expectationsANABTarget upside 75.1% vs 24.1%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ANAB and BAC and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
  • Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BAC.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

BAC lead: Weakening — the AIQ differential moved from 9 to 2 points over 30 sessions.

May 27ANAB leads above the line · BAC leads belowNov 13
Today
BAC +2
56 vs 58
7 sessions ago
BAC +1
57 vs 58
30 sessions ago
BAC +9
53 vs 62
90 sessions ago
BAC +12
59 vs 71

The lead changed hands 3 times in this window, most recently on Jul 17 when BAC moved ahead of ANAB.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ANAB

0 bullish / 3 bearish / 2 neutral

Only ANAB

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.60%)
  • Distribution Pattern — bearish, volume, medium horizon (1.22x)
BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)

Both carry 2 more signals that do not separate them: Death Cross Active, Downtrend Structure Active.

BAC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ANABConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -3.18%, AIQ -1 points).

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ANAB closes the Risk Resilience gap — currently 37 points behind, the largest single contributor to BAC's edge.
  2. 2ANAB's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 7 points over 30 sessions, and a further 2-point move would eliminate BAC's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ANAB leads on balance
MetricANABBAC
Revenue growth (YoY)10.1%-3.3%
EPS growth (YoY)-97.9%-23.8%
Gross margin143.7%60.4%
Operating margin34.6%22.4%
Return on equity (TTM)18.6%2.3%
Debt to equity0.61.28

Performance

BAC leads 4 of 6 windows
MetricANABBAC
1 week (5 sessions)-0.4%3.2%
1 month (20 sessions)-0.8%-0.4%
3 months (63 sessions)-22.5%-20.1%
6 months (126 sessions)-26.8%2.5%
Year to date-4.6%-7.2%
1 year (252 sessions)39.8%-5.7%

Technicals

BAC has the stronger structure
MetricANABBAC
RSI (14)42.745.9
ADX (14)23.727.2
Price vs 50-day-7.1%-5.6%
Price vs 200-day-18.1%-7%
Volatility (1M, annualized)51.8%24.8%

Risk

BAC is the more resilient
MetricANABBAC
Beta1.110.79
Sharpe ratio0.78-0.22
Sortino ratio1.11-0.29
Max drawdown-35.3%-23.7%
Current drawdown-34.1%-21.3%
Annualized volatility64.8%22.4%
Value at risk (95%)-5.3%-2.6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ANAB or BAC?

On the Algovestiq AIQ Score, BAC is the stronger of the two as of Nov 15, 2026, scoring 58 against ANAB's 56. The edge comes from risk resilience. ANAB is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ANAB or BAC the better buy right now?

BAC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.

Why does the AIQ Score favor BAC over ANAB?

The composite weights Quality, Value, Momentum and Risk Resilience. BAC leads Risk Resilience by 37 points; ANAB leads Quality by 8 points; ANAB leads Value by 6 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ANAB or BAC?

Analyst price targets imply +75.1% upside for ANAB and +24.1% for BAC, so the Street currently favors ANAB. That points the opposite way to the AIQ Score, which favors BAC. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ANAB or BAC?

ANAB is the better-valued of the two on the peer-relative Value factor. ANAB on the peer-relative Value factor, by 6 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ANAB or BAC?

BAC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ANAB or BAC?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ANAB or BAC?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 37 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ANAB more profitable than BAC?

ANAB leads on the comparable margin measures — gross margin 143.7% vs 60.4%; operating margin 34.6% vs 22.4%; ttm roe 18.6% vs 2.3%.

Is BAC's lead over ANAB getting stronger or weaker?

BAC lead: Weakening — the AIQ differential moved from 9 to 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-07-17, when BAC moved ahead of ANAB.

What would change the ANAB vs BAC verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ANAB closes the Risk Resilience gap — currently 37 points behind, the largest single contributor to BAC's edge; ANAB's Death Cross Active resolves — a bearish trend rule currently active against it; BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 7 points over 30 sessions, and a further 2-point move would eliminate BAC's advantage entirely.

What do the current signals say about ANAB and BAC?

ANAB: 0 bullish / 3 bearish / 2 neutral. BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ANAB is Death Cross Active (bearish, long horizon). On BAC it is Death Cross Active (bearish, long horizon).

Compare ANAB and BAC with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.